337 related articles for article (PubMed ID: 17145736)
41. Antigen-specific lymphocyte proliferation as a marker of immune response in guinea pigs with sustained Helicobacter pylori infection.
Miszczyk E; Walencka M; Rudnicka K; Matusiak A; Rudnicka W; Chmiela M
Acta Biochim Pol; 2014; 61(2):295-303. PubMed ID: 24918491
[TBL] [Abstract][Full Text] [Related]
42. Inflammatory large bowel disease in immunodeficient rats naturally and experimentally infected with Helicobacter bilis.
Haines DC; Gorelick PL; Battles JK; Pike KM; Anderson RJ; Fox JG; Taylor NS; Shen Z; Dewhirst FE; Anver MR; Ward JM
Vet Pathol; 1998 May; 35(3):202-8. PubMed ID: 9598583
[TBL] [Abstract][Full Text] [Related]
43. Campylobacter jejuni persistently colonizes gnotobiotic altered Schaedler flora C3H/HeN mice and induces mild colitis.
Wymore Brand M; Sahin O; Hostetter JM; Trachsel J; Zhang Q; Wannemuehler MJ
FEMS Microbiol Lett; 2020 Nov; 367(20):. PubMed ID: 33098301
[TBL] [Abstract][Full Text] [Related]
44. Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10-/- mice.
Eun CS; Mishima Y; Wohlgemuth S; Liu B; Bower M; Carroll IM; Sartor RB
Infect Immun; 2014 Jun; 82(6):2239-46. PubMed ID: 24643531
[TBL] [Abstract][Full Text] [Related]
45. Monitoring a mouse colony for Helicobacter bilis using a Helicobacter-genus-specific nested PCR.
Jacobsen K; Mahabir E; Brielmeier M; Wilhelm P; Seidel KE; Schmidt J
Lab Anim; 2005 Oct; 39(4):400-12. PubMed ID: 16197707
[TBL] [Abstract][Full Text] [Related]
46. Effect of Helicobacter bilis infection on human bile duct cancer cells.
Takayama S; Takahashi H; Matsuo Y; Okada Y; Takeyama H
Dig Dis Sci; 2010 Jul; 55(7):1905-10. PubMed ID: 19731027
[TBL] [Abstract][Full Text] [Related]
47. Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.
Maggio-Price L; Bielefeldt-Ohmann H; Treuting P; Iritani BM; Zeng W; Nicks A; Tsang M; Shows D; Morrissey P; Viney JL
Am J Pathol; 2005 Jun; 166(6):1793-806. PubMed ID: 15920164
[TBL] [Abstract][Full Text] [Related]
48. Neonatal co-infection with helicobacter species markedly accelerates the development of inflammation-associated colonic neoplasia in IL-10(-/-) mice.
Hale LP; Perera D; Gottfried MR; Maggio-Price L; Srinivasan S; Marchuk D
Helicobacter; 2007 Dec; 12(6):598-604. PubMed ID: 18001399
[TBL] [Abstract][Full Text] [Related]
49. Helicobacter bilis/Helicobacter rodentium co-infection associated with diarrhea in a colony of scid mice.
Shomer NH; Dangler CA; Marini RP; Fox JG
Lab Anim Sci; 1998 Oct; 48(5):455-9. PubMed ID: 10090057
[TBL] [Abstract][Full Text] [Related]
50. Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice.
Chichlowski M; Sharp JM; Vanderford DA; Myles MH; Hale LP
Comp Med; 2008 Dec; 58(6):534-41. PubMed ID: 19149410
[TBL] [Abstract][Full Text] [Related]
51. Enteric lesions in SCID mice infected with "Helicobacter typhlonicus," a novel urease-negative Helicobacter species.
Franklin CL; Riley LK; Livingston RS; Beckwith CS; Hook RR; Besch-Williford CL; Hunziker R; Gorelick PL
Lab Anim Sci; 1999 Oct; 49(5):496-505. PubMed ID: 10551450
[TBL] [Abstract][Full Text] [Related]
52.
Peng W; Zhao X; Li X
Biomed Res Int; 2022; 2022():1837850. PubMed ID: 35983246
[TBL] [Abstract][Full Text] [Related]
53. The microbiota and inflammatory bowel disease: insights from animal models.
Peloquin JM; Nguyen DD
Anaerobe; 2013 Dec; 24():102-6. PubMed ID: 23603043
[TBL] [Abstract][Full Text] [Related]
54. A microbial symbiosis factor prevents intestinal inflammatory disease.
Mazmanian SK; Round JL; Kasper DL
Nature; 2008 May; 453(7195):620-5. PubMed ID: 18509436
[TBL] [Abstract][Full Text] [Related]
55. Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats.
Dieleman LA; Hoentjen F; Qian BF; Sprengers D; Tjwa E; Torres MF; Torrice CD; Sartor RB; Tonkonogy SL
Clin Exp Immunol; 2004 Apr; 136(1):30-9. PubMed ID: 15030511
[TBL] [Abstract][Full Text] [Related]
56. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
57. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice.
Erdman SE; Poutahidis T; Tomczak M; Rogers AB; Cormier K; Plank B; Horwitz BH; Fox JG
Am J Pathol; 2003 Feb; 162(2):691-702. PubMed ID: 12547727
[TBL] [Abstract][Full Text] [Related]
58. Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response.
Whary MT; Morgan TJ; Dangler CA; Gaudes KJ; Taylor NS; Fox JG
Infect Immun; 1998 Jul; 66(7):3142-8. PubMed ID: 9632578
[TBL] [Abstract][Full Text] [Related]
59. Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease.
Lencioni KC; Seamons A; Treuting PM; Maggio-Price L; Brabb T
Comp Med; 2008 Dec; 58(6):522-33. PubMed ID: 19149409
[TBL] [Abstract][Full Text] [Related]
60. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.
Caradonna L; Amati L; Magrone T; Pellegrino NM; Jirillo E; Caccavo D
J Endotoxin Res; 2000; 6(3):205-14. PubMed ID: 11052175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
